EUCROF 2022 Conference: Madrid
Add short description here
Monday 7 February 2022
Time | Topic | Speaker |
---|---|---|
08:30 – 09:30 | Registration & Welcome Coffee | |
09:30 – 09:45 | Conference Opening | Martine Dehlinger-Kremer EUCROF & ICON Plc, Germany |
09:45 – 10:15 | The New Regulatory Landscape following the COVID-19 Pandemic | Edit Szepessy, European Commission, Belgium Fergus Sweeney, EMA, The Netherlands |
10:15 -10:45 | Coffee Break | |
Clinical Trial Regulation 536/2014 : Regaining Momentum Chair: Dagmar Chase | ||
10:45 – 11:15 | CTR and its Supportive Documents and Tools – Overview | Pieter Van Keerberghen, EMA, The Netherlands |
11:15 – 11:45 | CTR – a National Competent Authority Perspective | Maria Antonia Serrano, AEMPS, Spain |
11:45 – 12:15 | CTR – an Industry Perspective | Pierre Omnes, Syneos Health, France |
12:15 – 13:15 | Lunch | |
12:20 – 12:40 | World Courier: Satellite Symposium | |
Technology Innovations in Clinical Research and the COVID-19 Catalyst of Change Chair: Yvonne Rollinger/Sofoklis Kyriazakos/Fiona Maini | ||
13:15- 13:45 | Latest trends on Decentralized Clinical Trials enabled by Digital Health Technologies | Isaac Rodriguez Chavez, ICON Plc, USA |
13:45 – 14:15 | Hyper-accelerate clinical trials using an in silico approach | Luca Emili, InSilicoTrials, Italy |
14:15 – 14:45 | mHealthBelgium: a joint initiative for digital health by government and industry | Steven Vandeput, beMedTech, Belgium |
14:45 -15:15 | Coffee Break | |
The New Medical Device Regulation Environment and the Need for Clinical Evidence Chair: Antoinette van Dijk | ||
15:15 – 15:45 | Clinical investigations for conformity assessment purposes and other clinical investigations: what you need to know | Monique Al, CCMO, The Netherlands |
15:45 – 16:15 | Post Market Surveillance and Post Market Clinical Follow Up Plan under EU the MDR | Philippe Auclair, Abbott, Belgium |
16:15 – 16:45 | Medical Device Registry as a tool to provide evidence. The experience of Italy in implementing the National registry of implantable prostheses. (RIPI) | Marina Torre, Istituto Superiore di Sanità, Italy |
The rise of Big Data in pharmacoepidemiology Chair: Alexandre Malouvier | ||
16:55 – 17:25 | Determinants of COVID-19, impact on health care system and vaccination studies using the French national health data system | Laura Semenzato, CNAM, France |
17:25 | End of DAY 1 – Closing Remarks | Martine Dehlinger-Kremer, EUCROF & ICON Plc, Germany |
18:30 – 22:00 | Networking Dinner & Social Event |
Tuesday 8 February 2022
Time | Topic | Speaker |
---|---|---|
07:45 – 08:00 | Registration & Welcome Coffee | |
08:00 – 08:30 | Modernization of ICH E8 (R1) “General Considerations for Clinical Studies”: From 1997 to 2021 | Sigrid Balser, Boehringer Ingelheim, Germany |
08:30 – 09:00 | Update on ICH E6 (R3) ”Good Clinical Practice” and ICH E19 “Optimisation of Safety Data Collection” | Gabriele Schwarz, BfArM, Germany |
09:00 -09:30 | Coffee Break | |
Patient Centricity, beyond the Concept Chair: Leyre Malet | ||
09:30 – 09:55 | Patient generated health data (PGHD) | Rainel Sanchez-de la Rosa, Novartis, Switzerland |
09:55 – 10:20 | Freely Given Informed Consent: Challenges | Elmar Doppelfeld, Association of Medical Ethics Committees, Germany |
10:20 – 10:50 | Patient Centricity from Theory to Reality Moderated by Dimitrios Athanasiou | Jorge Mauriño, Roche, Spain Dimitrios Athanasiou, PDCO, EMA; EURORDIS; European Patient Forum, Greece Franck Devaux, EC Representative, Belgium |
Evolving Roles in a New Clinical Research Era Chair: Alexandre Malouvier/Benedikt Van Nieuwenhove | ||
11:00 – 11:30 | Clinical Trial Liaison: The new Medical Science Liaison: from medical affairs to clinical research | Sara Martin Dominguez, ICON Plc, Spain |
11:30 – 12:00 | Consequences of eSourcing on site performance | Maria Teresa García Morales, SCReN, Spain |
12:00 – 12:30 | Driving the Future Direction of Clinical Operations | Guillermo Badenes, Janssen, Spain |
12:30 – 13:15 | Lunch Break | |
12:40 – 13:00 | Evidenze: Satellite Symposium | |
Breaking News in Clinical Research Chair: Benedikt Van Nieuwenhove | ||
13:15- 13:35 | The GDPR Code of Conduct: Good Data Processing Practice for Service Providers in Clinical Research | Yoani Matsakis, Telemedicine Technologies, EUCROF, France |
13:35 – 13:55 | CRO Landscape Benchmarking in Europe | Gert-Jan Dossche, EUCROF, Belgium Benedikt Van Nieuwenhove, EUCROF, Belgium |
13:55- 14:25 | The Distributed TMF and the Decommissioning of Computerised Systems | Alan Yeomans, Viedoc, EUCROF, Sweden |
The Future of Clinical Research Chair: Antonio Torres | ||
14:25 – 15:10 | Panel Discussion, moderated by Doug Peddicord | Doug Peddicord, ACRO, USA Gabriele Schwarz, BfArM, Germany Dimitrios Athanasiou, PDCO, EMA; EURORDIS; European Patient Forum, Greece Rainel Sanchez-de la Rosa, Novartis, Switzerland Hisashi Uematsu, Japan Elmar Doppelfeld, Association of Medical Ethics Committees, Germany |
15:10-15:15 | Closing Remarks | Martine Dehlinger-Kremer, EUCROF & ICON Plc, Germany |